Navigation Links
GW Researcher receives grant to study parasitic worm role in bile duct cancer in Southeast Asia
Date:11/16/2012

WASHINGTON (Nov. 16, 2012) Paul Brindley, Ph.D., professor of microbiology, immunology, and tropical medicine at the George Washington University School of Medicine and Health Sciences, was the recipient of a $1.7 million grant from the National Cancer Institute to study the behavior of a parasitic worm, rampant in Southeast Asia, known to cause infections that contribute to liver cancer.

The idea for his project, titled "Role of Live Fluke Granulin in Cholangiocarcinogenesis," was introduced to Brindley several years ago by a Thai postdoctoral student. In Thailand, the student had seen a disproportionately large amount of instances of a specific type of bile duct cancer, not common in the Western Hemisphere. It was discovered that this type of bile duct cancer, cholangiocarcinoma, is brought on by a parasitic worm that lives in uncooked fresh water fish, often present in traditional dishes in the region. The worm thrives in Southeast Asia due to unsanitary practices and conditions. The cancer caused by the worm usually results in death.

"With this grant we will research how a parasite could cause cancer," said Brindley. "What is it doing in someone's liver or bile ducts that's turning otherwise normal tissue into a tumor?"

The worm, which is large enough to be seen without a microscope, releases a product called granulin while navigating through the human body. In humans and other mammals, granulin is used to stimulate cells to grow and divide in order to heal a cut or a wound. When a worm secretes granulin, it seems to enhance a tumorigenic environment.

"In an evolutionary sense, we don't see the value to a parasite of causing a tumor to grow around it," said Brindley. "If a person dies, the worm dies, too. Why would a worm induce a tumor?"

Over the next five years, Brindley's research team in the U.S., Australia, and Thailand will be focused on the effect this granulin secretion has on a human's liver cells. While a difficult hypothesis to prove, Brindley and his colleagues suggest that because there is a wound or lesion where the worm has passed, the worm intends to repair the damage it's causing by releasing granulin. That way, in a few days the worm could return to the same place and eat the cells again. If proven, a drug or medical treatment may be developed to help with the effects of granulin on tissue growth.


'/>"/>

Contact: Lisa Anderson
lisama2@gwu.edu
202-994-3121
George Washington University
Source:Eurekalert

Related medicine news :

1. Researchers outline effective strategies to prevent teen depression and suicide
2. Researchers report potential new treatment to stop Alzheimers disease
3. Feinstein Institute researchers discover plant derivative
4. Researcher: Military should reassess reproductive health care for women
5. GW researcher receives $4.1 million grant to find alternative treatment for kidney stones
6. Coca-Cola model for delivering malaria meds is a success, says Princeton researcher
7. Sociology, economics researchers receive grant to study development across the human lifespan
8. Emotional disconnection disorder threatens marriages, researcher says
9. Genital Injuries Common But Preventable, Researchers Say
10. Researchers identify impact of rheumatoid arthritis and lupus on joint replacement surgery outcomes
11. Moffitt Cancer Center researchers identify novel metabolic programs driving aggressive brain tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... The new knee compression sleeves ... to buy neoprene knee sleeves for lifting and any sport that requires ... on two main aspects to provide a higher quality knee sleeve performance. Firstly it ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... today that they have teamed up with The American College of Surgeons (ACS) ... ACS’s Committee on Trauma, the “Bleeding Control Basic” course is a pilot program ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... and many more tools allowing FCPX editors to create professional looking video in ... , Perfect Harmony contains a beautifully designed 3D environment for placing in ...
(Date:12/4/2016)... ... December 04, 2016 , ... "Pro3rd Displace ... animation styles with unique displacement design elements," said Christina Austin - CEO of ... Choose from a variety of design styles that include both left aligned and ...
(Date:12/2/2016)... ... 2016 , ... Halfway through its partnership with First 5 LA, Western University ... than 15,900 children 5 years old and younger and treatment services to more than ... of five years to Western University of Health Sciences, UCLA and USC, beginning March ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , December 5, 2016 PharmaBoardroom today releases ... . ... This report offers companies, investors, policymakers, and stakeholders crucial insight ... of Europe , home to some of the world,s ... pharmaceutical companies in Novartis and Roche, and with a number one ranking ...
(Date:12/5/2016)... VIENNA and TAIPEI, Taiwan , ... 12 months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea ... demonstrated a significantly better safety and tolerability profile of ropeginterferon ... data from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV ... PharmaEssentia intends to present this data to the ...
(Date:12/4/2016)... ORLEANS , Dec. 2, 2016  Former Attorney General ... Jr., Esq. , a partner at the law firm of ... commenced an investigation into Lannett Company, Inc. (NYSE: ... Bloomberg published an article titled "U.S. Charges in Generic-Drug ... "antitrust investigation by the Justice Department, begun about two years ...
Breaking Medicine Technology: